Capillary-Based AST Platform for Faster Optical Susceptibility Testing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial susceptibility testing (AST) methods are limited by their complexity, need for overnight incubation, and high cost, making them unsuitable for point-of-care applications and resource-limited settings, which increases the risk of mortality in patients with severe infections.
Innovation Solution
A capillary-based AST platform (cAST) using capillary tubes with integrated light sources and detectors for real-time spectral measurements of bacterial growth, enabling rapid determination of antimicrobial susceptibility within 4-8 hours with reduced sample volumes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional AST methods (broth dilution, disk diffusion) are used, then antimicrobial susceptibility can be determined, but the process requires overnight incubation (16-24 hours) which delays treatment decisions
Solution Approach 1:
The patent changes the detection parameter from traditional turbidity measurement to optical absorption spectroscopy at multiple wavelengths. This enables real-time monitoring of bacterial growth kinetics and allows determination of antimicrobial susceptibility within 4-8 hours by analyzing growth curves and calculating area-under-the-curve metrics, resolving the time delay issue while maintaining measurement accuracy
Solution Approach 2:
The patent replaces the manual visual inspection method with an automated optical detection system that uses light absorption measurements at multiple wavelengths to detect bacterial growth. This substitution enables continuous real-time monitoring and automated analysis, reducing the incubation time from overnight to 4-8 hours while maintaining precision in susceptibility determination
2Productivity
If automated broth microdilution methods are used, then real-time measurements can be detected, but the cost of instruments and consumables is high, limiting accessibility for point-of-care applications
Solution Approach 1:
The patent uses disposable capillary tubes as reaction vessels instead of expensive automated microdilution systems. The capillary tubes are inexpensive, single-use items that eliminate the need for costly automated instrumentation while still enabling real-time optical measurements. This approach maintains productivity through real-time detection capability while dramatically reducing device complexity and cost for point-of-care deployment
Solution Approach 2:
The patent extracts the core measurement function from complex automated systems and implements it using simple optical absorption measurements through capillary tubes. By taking out only the essential real-time detection capability and implementing it with inexpensive optical components, the system achieves real-time measurement productivity without the high instrument costs that limit accessibility
3Ease of operation
If manual preparation of inocula is required, then broth microdilution can be performed, but the workflow complexity increases and accessibility to point-of-care is reduced
Solution Approach 1:
The patent employs capillary action to automatically fill the capillary tubes with the bacterial inoculum and culture medium. The capillary tubes self-fill through their own capillary forces without requiring manual pipetting or complex dispensing equipment. This self-service mechanism dramatically simplifies the workflow, making the system easy to operate and highly adaptable for point-of-care settings where manual dexterity and specialized equipment may be limited
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cAST platform provides accelerated AST results, reducing the time to detection by approximately 25% compared to conventional methods, making it suitable for point-of-care use and resource-limited settings while maintaining accuracy.
Implementation Method 1
The conduit may comprise a capillary tube
Implementation Method 2
a light source positioned or positionable at a first end of the conduit to output light along a longitudinal axis of the conduit. The system also comprises iii) a light detection device positioned or positionable at a second end of the conduit to receive light transmitted through the conduit by the light source
Data Source
AI summary
Provided are systems, devices, kits, and methods that are used for antimicrobial sensitivity testing (AST). The systems, devices, kits, and methods provide a capillary-based antimicrobial susceptibility testing platform referred to as “cAST” that provides faster determination of antimicrobial susceptibility using lower sample volumes than previous approaches. The cAST approach includes performing AST by measuring colorimetric or fluorescent signal changes in samples in conduits that contain antimicrobial agents and one or more dyes. The conduits are operably linked to a light source and a light detecting component through a mount configured to hold the conduits and thereby determine changes in light that indicates changes in bacteria growth in the present of the antimicrobial agents.